Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Sir Auric Goldfinger who wrote (2788)	7/22/1999 8:42:00 PM
From: Ben Wa	Read Replies (1) \| Respond to of 4140

Their last fed filing shows 43 million primary shares outstanding. Even a $3 stock price means a mkt cap of over a hundred milsky. It will be interesting to see the balance sheet from their June quarter & I would expect an 8-K to be filed as a result of the FDA meeting. My gut feel says "fair value" given their own wording in their last fed filing says fair value would be around $10-20 million million mkt cap, with the knowledge (my interpretation of their own words)that they may need to raise more money, which after today could take the form of a convert with pretty onerous terms. A $20 million mkt cap would give a price under $1 per share, but due to the big short position, I think it will take months to get anywhere near that level. (short covering, etc.) just my little opinion